NEW YORK, July 15 /PRNewswire-FirstCall/ -- Senesco Technologies (NYSE Amex: SNT) announces the following Webcast:
What: LHA Life Sciences & Med Tech Day 2010 Presentation
When: July 20, 2010 @ 12:30 PM Eastern
Where: http://www.investorcalendar.com/ClientPage.asp?ID=160518
How: Live over the Internet -- Simply log on to the web at the address above.
Contact: Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=160518 or http://www.investorcalendar.com/
Senesco Technologies (NYSE Amex: SNT) is leveraging proprietary technology that regulates cell death, or apoptosis. Accelerating apoptosis may have application in treating cancer, while delaying apoptosis may have application in certain inflammatory and ischemic diseases. The Company is preparing to initiate a human clinical trial in multiple myeloma with its lead therapeutic SNS-01. Senesco also has partnered with leading-edge companies engaged in agricultural biotechnology, and earns research and development fees for applying its gene-regulating platform technology to enhance its partners’ products. For more information about the Company, please visit www.senesco.com.
SOURCE Senesco Technologies
